Chamber and committees

The following formal flood protection schemes are complete.

Data published by Public Health Scotland covering the period 01 January 2020 to 30 September 2021 shows that in NHS Grampian 83.7 % eligible referrals started treatment within the 62 day standard in 2020 and 78.2% in 2021. Representing 1081 of 1,291 referrals in 2020 and 815 of 1,042 referrals in 2021.

Further breakdown of this data can be accessed at Cancer waiting times - 1 July to 30 September 2021 - Cancer waiting times - Publications - Public Health Scotland .

Boards are continuing to prioritise new cancer patients being referred with a suspicion of cancer - this is closely monitored through weekly performance meetings with officials and reflected in Boards’ Remobilisation Plans.

A refresh of the Framework for Effective Cancer Management is underway and will support clinicians and NHS managers to drive improvements in cancer pathways, providing Health Boards with the tools to effectively manage cancer patients and ultimately recover waiting times.

£10 million of funding has been directed to support cancer waiting times improvements in NHS Scotland across 2021-22, including up-skilling nurses and investing in diagnostic tests to extended working days and weekend working, to increase capacity and see/treat cancer patients as timely as possible. NHS Grampian received £974,000 as a share of the funding.

The Scottish Government continues to closely monitor all emerging evidence on the effectiveness of COVID-19 treatments and their clinical effectiveness. The Medicines and Healthcare products Regulatory Agency (MHRA) is now assessing Paxlovid’s safety and effectiveness, and I cautiously welcome analysis of the final clinical trial results from Pfizer (which are yet to be published or verified) which show that Paxlovid cuts the risk of hospitalisation or death by approximately 89% in high risk, non-hospitalised adult patients with mild-to-moderate COVID-19. If approved by the MHRA, this will represent another significant pharmaceutical option in our response to COVID-19.

On 20th October, the UK Government announced that 250,000 treatment courses of Paxlovid had been ordered, pending regulatory approval. On 22nd December, the UK Government announced that a further 2.5 million treatment courses had been ordered as part of efforts to reduce the impact of COVID-19 and the Omicron variant across the UK. If authorised by the MHRA, the intention is to initially deploy antivirals such as Paxlovid to individuals through a UK-wide national study, funded by the National Institute for Health Research (NIHR). The University of Oxford has been selected to lead the study . This will enable collection of additional data to address limitations in the company-sponsored trials, for example the effectiveness of the treatments in vaccinated patients, as participants in the company trials were unvaccinated.

Many dental procedures involve the use of an aerosol which, for the safety of both patients and staff, needs to be done under strict Infection Prevention and Control guidelines. This means that NHS dental teams are unable to see the same numbers of patients as before the start of the pandemic.

From February 2022, we will bring in new and increased fees for dentists for a range of treatments, supporting them in their efforts to clear the backlog which has built up during the pandemic. We have already provided £50 million of additional financial support (on top of the budget for General Dental Services), plus supplied £30-£35 million of free PPE, to ensure NHS dental services emerge well-placed to care for the oral health of everyone in Scotland.

Claims of bullying behaviour by civil servants are untrue. All members of the National Advisory Committee for Chronic Pain (NACCP) are free to make whatever contribution they wish to discussions.

All committee members are required to abide by the behaviours set out in the Terms of Reference, including the values of respect and mutual collaboration to agree recommendations to help improve care for people with chronic pain. If these behaviours and values were not met, this would be taken very seriously and addressed.

As at December 2021 four representatives of the Chronic Pain Patient Reference Group attending the NACCP had written to officials to resign their positions. Two resignations took place in June 2021, with one in each of October and November 2021. It would not be appropriate to divulge the specific reasons cited by each individual, however I am clear that officials acted on the relevant feedback provided.

For example, as a result we are currently reviewing existing stakeholder engagement processes and structures around our work on chronic pain, including the role of the NACCP. The outcome of this work is intended to ensure meaningful engagement to support the future delivery and implementation of the Framework for Pain Management Service Delivery following completion of the current public consultation.

The Open Market Shared Equity scheme is targeted at first time buyers on low to moderate incomes regardless of the source of their income. This includes those in employment and in receipt of benefits. In 2020-21, the average gross household income of beneficiaries was £27,000 and 43% of households had at least one child.

I refer the member to the answer to question S6W-04082 on 9 November 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

Asylum is reserved to the UK Parliament and handled by the Home Office. Asylum accommodation is delivered under Home Office contracts, with Mears Group holding the contract for Scotland. Responsibility under that contract includes meeting standards for undertaking any necessary repairs in accommodation.

The Scottish Government regularly engages with Mears Group, COSLA and Glasgow City Council across a range of asylum matters.

The Scottish Government is committed to providing clear information and support for people with long COVID. To help raise awareness of symptoms and signpost people to appropriate support, a marketing campaign ran in October and November 2021. The campaign budget was invested in: print and production of campaign posters for display in community pharmacies and GP surgeries across Scotland, language translations, social media posts and a campaign toolkit sent to 250 direct partner contacts with additional distribution of approximately 3,000 contacts.

The campaign directed people to the long COVID microsite hosted by NHS Inform, accessible at www.nhsinform.scot/long-covid . The microsite had nearly 86,000 users during the campaign period.

The Scottish Government has been working collaboratively with public and third sector partners to create and disseminate COVID-19-related information to asylum seekers and refugees in relevant languages and accessible formats. Given the fast-moving nature of coronavirus-related guidance, we took into consideration the lead time with translations and the danger of out-of-date messages being shared and distributed, and focused on working in partnership to create and distribute key coronavirus information to benefit the wider community.

1. The Scottish Government works closely with NHS 24 and Public Health Scotland to ensure key public health information on COVID-19 is available in 17 languages and accessible formats via the NHS Inform website, which is Scotland’s central repository for public health information.

2. In July 2021 Dari and Pashto translations were added to NHS Inform in response to the Afghan Relocation and Assistance Policy (ARAP) scheme.

3. In addition to NHS Inform, the COVID helpline provides interpreter services to support engagement with people whose first language is not English.

4. COVID-19 National Door Drops that have been sent to all homes in Scotland for Covid-19, Test and Protect and COVID-19 Vaccines and Right Care Right Place were created in key languages for asylum seekers and refugees as identified by partners.

5. We have been working in partnership with NHS Scotland and Public Health Scotland to spread the message of available translations and formats. Organisations reached include: Scottish Refugee Council; BEMIS (the national umbrella body supporting the development of the Ethnic Minorities Voluntary Sector in Scotland); NHS Lothian Minority Ethnic Inclusion Service (MEHIS); British Red Cross; Inclusion Scotland; Scottish Independent Living Coalition (SILC); Progress in Dialogue; Article 12.

6. SG and PHS have engaged with various organisations including the Scottish Refugee Council to get feedback on how to maximise COVID-19 vaccine uptake with asylum seekers and refugees, and in response to identified needs, videos, a Statement of Facts sheet and informed consent information have been developed in relevant languages to provide information about issues identified as concerns across a range of population groups in Scotland.